Anagenics Ltd has released a press release.
FY24 4E Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- Appendix 4E and Preliminary Final Report
- Company Update License Partnership Announcement
- Appendix 4C Cash Flow & Activities Report
- Midkine Antibody Licensing Deal
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Anagenics
- Pause in Trading
- Suspension from Official Quotation
- Market Update
- 2024 Anagenics Annual Report
- Q1 F25 Activity Statement and Appendix 4C
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics